Celldex Therapeutics Inc.
Organization details
- Legal name
- Celldex Therapeutics Inc.
- Former names
- Avant Immunotherapeutics Inc T Cell Sciences Inc
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2835 — In Vitro & In Vivo Diagnostic Substances
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Hampton
- Headquarters state / province
- New Jersey
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- CLDX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0000744218
- EIN
- 13-3191702
Board of directors
-
Anthony S. Marucci · Director · PRESIDENT & CEOSince 2023
-
Cheryl Cohen · DirectorSince 2023
-
Denice Torres · DirectorSince 2025
-
Garry Arthur Neil · DirectorSince 2023
-
Harry Penner Jr. · DirectorSince 2023
-
Herbert J. Conrad · DirectorSince 2023
-
James J. Marino · DirectorSince 2023
-
Karen L. Shoos · DirectorSince 2023
-
Keith L. Brownlie · DirectorSince 2023
- Since 2023
Chief executives
Director election results
Annual meeting of June 25, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
98.4%
-
98.4%
-
98.5%
-
98.9%
-
99.0%
-
99.3%
-
99.4%
Board connections
6 of this board's directors also sit on 10 other boards. 10 are in the same sector.
-
Avalo Therapeutics Inc. Same sectorvia Garry Arthur Neil and Rita Jain
-
AnaptysBio Inc. Same sectorvia Rita Jain
-
First Tracks Biotherapeutics Inc. Same sectorvia Rita Jain
-
Glaukos Corporation Same sectorvia Denice Torres
-
ImmunityBio Inc. Same sectorvia Cheryl Cohen
-
Matinas Biopharma Holdings Inc. Same sectorvia Herbert J. Conrad
-
SAB Biotherapeutics Inc. Same sectorvia Rita Jain
-
Seaport Therapeutics Inc. Same sectorvia Denice Torres
-
Traws Pharma Inc. Same sectorvia James J. Marino
-
Zura Bio Limited Same sectorvia Garry Arthur Neil
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $1,304,383
- 2 sales by 2 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 2, 2026 | Martin Samuel Bates Officer (SVP AND CFO) | Option exercise | +4,817 | $10.38 | $50,000 |
| Dec 15, 2025 | PEPIN RONALD Officer (SR. VP & CBO) | Option exercise | +8,333 | $9.02 | $75,164 |
| Dec 15, 2025 | PEPIN RONALD Officer (SR. VP & CBO) | Option exercise | +11,000 | $2.78 | $30,580 |
| Dec 4, 2025 | Jimenez Freddy A. Officer (SVP & GENERAL COUNSEL) | Open-market sale | −4,166 | $29.10 | $121,231 |
| Nov 13, 2025 | Wright Richard M. Former Officer | Option exercise | +6,876 | $9.02 | $62,022 |
| Nov 13, 2025 | Wright Richard M. Former Officer | Option exercise | +26,672 | $10.38 | $276,855 |
| Nov 13, 2025 | Wright Richard M. Former Officer | Option exercise | +15,750 | $22.48 | $354,060 |
| Nov 13, 2025 | Wright Richard M. Former Officer | Open-market sale | −49,298 | $24.00 | $1,183,152 |
| Aug 13, 2025 | Jimenez Freddy A. Officer (SVP & GENERAL COUNSEL) | Open-market sale | −341 | $23.95 | $8,167 |
| Aug 13, 2025 | Jimenez Freddy A. Officer (SVP & GENERAL COUNSEL) | Open-market sale | −430 | $25.42 | $10,931 |
| Nov 18, 2024 | James J. Marino Director | Gift | −10,500 | — | — |
| Nov 11, 2024 | Anthony S. Marucci Director, Officer (PRESIDENT & CEO) | Open-market purchase | +11,500 | $26.82 | $308,430 |
| Jun 14, 2024 | Martin Samuel Bates Officer (SVP AND CFO) | Option exercise | +3,201 | $9.02 | $28,873 |
| Jun 14, 2024 | Crowley Elizabeth Officer (SR. VP & CPDO) | Option exercise | +30,000 | $10.38 | $311,400 |
| Jun 14, 2024 | Martin Samuel Bates Officer (SVP AND CFO) | Option exercise | +16,968 | $10.38 | $176,128 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Celldex Therapeutics Inc.
Who is the CEO of Celldex Therapeutics Inc.?
Anthony S. Marucci is Celldex Therapeutics Inc.'s PRESIDENT & CEO.
How many directors are on Celldex Therapeutics Inc.'s board?
Celldex Therapeutics Inc.'s board has 10 directors: Anthony S. Marucci, Cheryl Cohen, Denice Torres, Garry Arthur Neil, Harry Penner Jr., Herbert J. Conrad, James J. Marino, Karen L. Shoos, Keith L. Brownlie and Rita Jain.
Are Celldex Therapeutics Inc. insiders buying or selling shares?
Over the last 12 months, Celldex Therapeutics Inc. insiders made no open-market purchases and sold $1.3 million of shares in 2 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="celldex-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.